Share:
BIRMINGHAM, ALABAMA – 04 March, 2021 – BioGX Sample-Ready™ lyophilized qPCR technology was selected by the NASA WetLab-2 program in 2016 to conduct genetic analysis in a microgravity environment aboard the International Space Station (ISS). Five years and several launches later, the collaboration is still going strong with a track record of success.
The International Space Station (ISS) is the world’s leading laboratory for cutting-edge research and innovation. “We are proud to be NASA’s partner in their quest for high-performing, innovative molecular chemistries. Our outer space innovations find their way in creating best in class molecular diagnostics solutions for any lab setting, here on earth” said Shazi Iqbal, Ph.D., CEO of BioGX.